Related Experiment Video
Updated: Jun 2, 2026

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities
Published on: February 20, 2021
Air kerma standard and measurement comparison on source strength determination for high-dose rate 192Ir brachytherapy
Jeng-Hung Lee1, Shi-Hwa Su, Ming-Tsung Hsieh
1Health Physics Division, Institute of Nuclear Energy Research, 1000, Wen-Hua Road, Longtan Township, Taoyuan County 32546, Taiwan.
Abstract:
This paper describes the establishment by the Institute of Nuclear Energy Research (INER, Taiwan) of the reference air kerma rate (RAKR) calibration standard for measurement of high-dose rate (HDR) (192)Ir brachytherapy source strength. A bilateral comparison has been made in the RAKR standards for HDR (192)Ir brachytherapy sources at the INER and Physikalisch-Technische Bundesanstalt (PTB, Germany) and the measurement difference was within the overall standard uncertainty and showed good agreement between the two calibration standard systems established at the INER and the PTB. Besides, INER also worked with 20 domestic hospitals to organise an on-site measurement comparison programme to explore the status of HDR (192)Ir brachytherapy source strength determination in Taiwan. The comparison results presented the ratios of RAKR with vendor values, as determined by INER and hospitals from the programme. The ratios fall in all cases within the ± 3 % guaranteed by the vendors for a coverage factor of k = 2 or at 95 % confidence level.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
07:31Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Related Concept Videos
Biological Effects of Radiation
Atomic Absorption Spectroscopy: Radiation and Light Sources
Two common narrow-range 'line' sources used in AAS are hollow-cathode lamps (HCLs) and...